Sustained-release dosage form of nicardipine hydrochloride: Application of factorial design and effect of surfactant on release kinetics

被引:0
|
作者
Ozyazici, M
Sevgi, F
Ertan, G
机构
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Microcapsules of nicardipine hydrochloride with core:wall ratios of 1:1, 2:1, and 1:2 were prepared by the coacervation-phase separation method, using ethylcellulose as the coating material. Two batches of nicardipine hydrochloride microscapsules were divided into size fraction by using standard sieves ranging from 840 mu m to 476 mu m. Dissolution rate studies from microcapsules were performed using the USP XXII basket method. The kinetic model according to the Rosin-Rammler-Sperling-Bennet-Weibull (RRSBW) distribution was applied for the parametric representation of the dissolution curves. Preparation and dissolution rate studies on the nicardipine hydrochloride microcapsules were performed and the influence of particle size, core:wall ratio, and the amount of nicardipine hydrochloride on the release rate was examined by 2(3) factorial design. The significance of the observed effects was tested with the F test. A surface active substance was added in the dissolution medium to understand how this substance effects the release of drug from ideal microcapsule form which is found by the findings of the 2(3) factorial design. Dissolution studies were repeated with this ideal formulation using different ratio of Tween 20. The results of this study suggested that the solubility and bioavailability of the sustained-release dosage forms of nicardipine hydrochloride using surface active substances could be increased.
引用
收藏
页码:761 / 770
页数:10
相关论文
共 50 条
  • [22] BLOOD-LEVELS FROM A SUSTAINED-RELEASE DOSAGE FORM
    DOBRINSKA, MR
    WELLING, PG
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (10) : 1728 - 1729
  • [23] HYDRODYNAMICALLY BALANCED SYSTEMS AS SUSTAINED-RELEASE DOSAGE FORMS FOR PROPRANOLOL HYDROCHLORIDE
    KHATTAR, D
    AHUJA, A
    KHAR, RK
    PHARMAZIE, 1990, 45 (05): : 356 - 358
  • [24] SUSTAINED-RELEASE FORM OF SULFAMETHAZINE
    GOODWIN, DE
    ELLISON, T
    BUCY, CB
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1967, 151 (02) : 160 - &
  • [25] Sustained-release formulation of sarpogrelate hydrochloride
    Hye Jin Kim
    Dae Hwan Shin
    Eun Ah Lim
    Jin-Seok Kim
    Archives of Pharmacal Research, 2015, 38 : 35 - 41
  • [26] ORAL SUSTAINED-RELEASE DOSAGE FORMS
    KRAUSE, GM
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1966, 30 (02) : 261 - &
  • [27] Sustained-release formulation of sarpogrelate hydrochloride
    Kim, Hye Jin
    Shin, Dae Hwan
    Lim, Eun Ah
    Kim, Jin-Seok
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (01) : 35 - 41
  • [28] Novel sustained release and swellable gastroretentive dosage form for ciprofloxacin hydrochloride
    Gaikwad, Vinay Dhananjay
    Yadav, Vishal Dadasaheb
    Gaikwad, Manish Dhananjay
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2014, 4 (02) : 88 - 92
  • [29] PHARMACOKINETIC DETERMINANTS IN THE DESIGN AND EVALUATION OF SUSTAINED-RELEASE DOSAGE FORMS
    BOXENBAUM, H
    PHARMACEUTICAL RESEARCH, 1984, (02) : 82 - 88
  • [30] THEOPHYLLINE, SUSTAINED-RELEASE FORMULATION - DESIGN OF OPTIMAL DOSAGE REGIMEN
    KOZJEK, F
    MRHAR, A
    KARBA, R
    BREMSAK, F
    LENARDIC, A
    ACTA PHARMACEUTICA JUGOSLAVICA, 1983, 33 (01): : 7 - 14